GeoVax Labs, Inc. (GOVX) stock
GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.99−0.02 (-1.00%)
Close on Nov 18, 2026Market cap $14.66MP/E –Yield –
GeoVax Labs price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
GeoVax Labs's price to sales ratio was 54.1× on Jul 31, 2026, against 64.6× a year earlier. Over the last 3 years it ranged from 0.0× to 458.9×, with a median of 71.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 54.1× | +16.2 |
| 2025 | Dec 31, 2025 | 37.9× | −421.1 |
| 2020 | Feb 28, 2020 | 458.9× | +399.0 |
| 2019 | Sep 30, 2019 | 59.9× | −16.3 |
| 2018 | Dec 31, 2018 | 76.2× | – |
See a number that looks wrong?